Press "Enter" to skip to content

GSK’s HIV drug wins European panel thumbs-up

GlaxoSmithKline Plc’s two-drug treatment for HIV infections won marketing approval from a European Medicines Agency (EMA) panel on Friday, after the British drugmaker received a nod from the U.S. Food and Drug Administration earlier this month.

Original source:

Also Read:   Trump says he is holding big Pharma accountable in opioid fight